The present disclosure is generally related to systems and methods for compensating for patient motion in medical imaging applications.
In medical imaging of the thoracic cavity, intrafraction movement can have a significant effect on medical imaging quality. Intrafraction movement occurs when the patient and/or organs within the thoracic cavity (e.g., lungs, heart, etc.) move during an imaging scan. Respiratory movement, in particular, can have a significant affect on image quality and can produce a variety of artifacts (e.g., blur, distortion, etc.) within a medical image. These imaging artifacts can in turn affect the extent to which medical practitioners can rely on a medical image for diagnoses or for treatment planning. For example, in order to compensate for any uncertainties created by imaging artifacts, radiologists may need to over estimate a target treatment volume in a patient.
In general, there exist several techniques to account for respiratory motion in medical imaging. For example, these techniques can including breath-hold, respiratory gating or breathing coaching, which employs visual and/or audio feedback regarding when a patient should inhale and/or exhale. By controlling a patient's breathing in either of these manners, the amount of image artifacts can be reduced to an extent. Unfortunately, however, such breath-hold and coaching techniques are limited. For example, only about 40% of the lung cancer population can hold their breath for an adequate duration of time, and breathing coaching cannot account for irregular motion of the lungs (or irregular motion of tissues adjacent the lungs).
In the drawings, identical reference numbers identify similar elements or acts. The sizes and relative positions of elements in the drawings are not necessarily drawn to scale. For example, the shapes of various elements and angles are not drawn to scale, and some of these elements are arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn are not intended to convey any information regarding the actual shape of the particular elements, and have been solely selected for ease of recognition in the drawings.
A. System Overview
The following disclosure is directed towards compensating for intrafraction movement in medical imaging systems, for example, compensating for respiratory motion in 4-dimensional computed tomography (CT) imaging systems, including axial CT, helical CT, and ciné CT imaging systems. Well-known characteristics often associated with medical imaging systems and associated signal/data processing have not been shown or described in detail to avoid unnecessarily obscuring the description of the various embodiments. Those of ordinary skill in the relevant art will understand that additional embodiments may be practiced without several of the details described below, and that other embodiments may include aspects in addition to those described below.
The localization subsystem 140, in operation, employs one or more (implantable) active markers 142 adjacent the PTV that can be tracked or monitored. The active markers, for example, are electrically active, generating detectable electromagnetic pulses when excited by an external source (described further with reference to
In contrast to the system 100, conventional imaging systems are limited by conventional techniques for (intrafraction) motion compensation. For example, as described above, breath-hold, respiratory gating can only be used on a minority of the cancer patient population, and breathing coaching can at best only account for predicable types of respiratory motion. Furthermore, other types of motion compensation techniques can only provide coarse approximations of a PTV location. For example, one conventional technique employs surrogate markers that are externally affixed to a patient's chest or abdomen, at a location that roughly corresponds with the internal location of a PTV. An Infrared radiation source can be used to illuminate the surrogate markers, and a video camera can use reflected radiation to track the movement of the surrogate. Although providing a rough approximation of respiratory motion, surrogate markers are not directly located at the PTV, and thus they are limited in accuracy. For example, during a patient's breathing cycle, the distance between the PTV and the surrogate markers can vary non-linearly and/or unpredictably. Surrogate markers cannot account for these non-linear and unpredictable types of motion. Consequently, in many surrogate marker techniques, the localization data is a predictive measure that determines a suitable gating window. For example, such a gating window can predict the times at which a patient's lungs should be in an inhaled or exhaled state, and raw image data can accordingly be gathered when the lungs are in either of these states. However, if a patient's breathing deviates from this predicted cycle, the raw image data loses accuracy.
Another conventional motion compensation technique includes implanting opaque fiducials at a PTV and correlating fiducial motion with the motion of surrogate markers. For example, a PTV can be imaged for a first period of time, and the location of the fiducials can be separately assessed during a second period of time. This process can be repeated until a motion map of the PTV is acquired, for example, by imaging once every 10 seconds and monitoring the fiducials between the imaging intervals. Generally, this type of motion compensation technique is complicated, has time-intensive set-up procedures, and is only effective for a minority of patients. Furthermore, the fiducial motion is not captured in real-time, nor does the fiducial motion represent accurate organ or tissue motion over relatively short time intervals (e.g., for intervals that are less than 10 seconds).
Embodiments of the imaging and localization system 100, however, overcome these and other limitations associated with conventional motion compensation techniques. For example, the raw image data of the system 100 can be processed based on the real-time PTV position and not exclusively on the predicted or approximated position of the PTV (i.e., derived by surrogate markers or from breath coaching techniques). Accordingly, the system 100 can account for a variety of non-linearities and unpredictable motion of the PTV. In addition, individual markers can transmit a unique electromagnetic signal, allowing the system interface 130 to identify and distinguish between individual markers. Surrogate markers and opaque fiducials, on the other hand, can only be discriminated optically with complicated and manually-intensive imaging procedures. Furthermore, unlike externally positioned surrogate markers, which can be inadvertently repositioned (e.g., by physical contact with the surrogate marker), implantable markers generally remain fixed to soft tissue within a patient and move with motion of soft tissue that they are rigidly fixed to. Accordingly, the implantable markers can reduce or eliminate patient-setup positioning errors.
B. System Components and Operation
The imaging subsystem 110 also includes a signal processing unit 230 (drawn in phantom) that is operably coupled with the imaging device(s) 218 for collecting raw image data regarding the PTV of the patient. In general, the signal processing unit 230 can carry out a variety of processing algorithms that assemble or otherwise construct image slices or image frames (based on the image slices), for example, to produce a digitally reconstructed radiograph (DRR). In several embodiments, the signal processing unit 230 can also produce raw image data according to a digital imaging and communication in medicine (DICOM) standard or interface with another system (not shown) that formats data into such a standard. In addition, in many examples, the signal processing unit 230 is also operably coupled with the gantry 212 and/or the table 216 for positioning the imaging device(s) 218 with respect to the PTV. For example, the signal processing unit 230 can be configured to control the rate at which the imaging device(s) 218 rotate and/or the rate at which the table 216 moves through the gantry bore 214. In many embodiments, the configuration of the gantry 212, gantry bore 214, table 216, the imaging device(s) 218, and/or the processing unit 230 is suited for CT-based imaging. However, in other embodiments, other imaging subsystems can include additional or alternative components that are suited for other types of imaging (e.g., fluoroscopic, MRI, PET, or ultrasonic imaging). Furthermore, although not shown in
Turning now to
The localization subsystem 140 also includes one or more signal processing/control components 360 that can be integrated into a common assembly with the excitation source 352 and sensor array 354 and/or can be incorporated into a stand-alone operator interface (not shown). In general, the signal processing/control components 360 are configured to (a) use the excitation source 352 to wirelessly deliver a pulsed magnetic field to energize individual markers 142, (b) receive a location signal from the individual markers 142 via the sensor array 354, and (c) periodically calculate a location of the individual markers 142 in a reference frame. Because the individual sensors 356 of the sensor array 354 are spaced apart from one other in a known geometry relative to each other, the absolute location of the individual markers can be determined by a known location (e.g., a known location of one of the sensors 356 or another external sensor). The dimensionality of localization, alignment and/or registration of the PTV can be determined based on the known location and the number of active markers deployed at or adjacent the PTV. For example, a single marker defines a single position in localization space; two markers can be used to register the distance between two points. Furthermore, two independent sets of two markers attached to soft tissue can be used to register and align two vectors relative to each other. And, three markers attached to soft tissue relative to each other can be used to define a plane including rotational angles of the plane (i.e. pitch, yaw and roll). A variety of processing algorithms can provide such a determination, examples of which are set forth in U.S. application Ser. Nos. 10/679,801; 10/749,478; 10/750,456; 10/750,164; 10/750,165; 10/749,860; and 10/750,453, all of which are incorporated herein by reference.
In many applications, active markers can be directly affixed to the PTV or to organs or tissues adjacent the PTV. For example, in applications that image portions of the lungs or lung tumors, a bronchoscope along with visual and fluoroscopic guidance can be used to direct a guide wire to bronchi locations. The guide wire can be used to wedge the individual markers as distally as possible to maximize fixation of the markers within the lungs. In many embodiments, such techniques are minimally invasive, and can position the markers as close as possible to the PTV without employing more invasive techniques. In other embodiments, however, other types of procedures may be used to position the markers at the PTV (e.g., laparoscopic implantation).
Embodiments of the individual marker 142 can include a transponder 343 contained in a biocompatible capsule 344 and having a core 345, a coil 347 around the core 345, and a capacitor 349 electrically coupled to the coil 347. The core 345 is typically composed of ferrite, and the coil 347 includes a plurality of windings of a wire around the core 345. The transponder 343 is a resonating circuit that receives the wirelessly transmitted magnetic excitation energy and produces a wirelessly transmitted location signal in response to the excitation signal. The transponder 343 accordingly has a resonant frequency at which the magnetic excitation energy energizes the transponder 343. In many embodiments, individual markers 142 can have transponders having resonant frequencies that are different from one another (e.g., for signal discrimination). Embodiments of suitable markers can also include, for example, the markers shown and described in U.S. Pat. Nos. 7,135,978, 6,918,919 and 6,822,570; U.S. application Ser. Nos. 10/334,700; 10/679,801; 10/382,123; 10/745,097; 10/746,888; and 11/166,801, all of which are incorporated herein by reference.
Referring now to
Embodiments of the system interface 170 can also include a synchronization link 482 and/or a feedback link 484 between the system interface 170 and the imaging subsystem 110. The imaging subsystem 110 can communicate a synchronization signal over the synchronization link 482, and the system interface 170 can communicate a feedback signal over the feedback link 484. In many examples, the synchronization signal can be used by the system interface 170 to align raw image data with real time localization data. For example, to compensate for respiratory motion, a synchronization signal can create a time indicator as to when a patient's lungs are fully inhaled and/or fully exhaled. Accordingly, the real-time localization data can then be correlated with the phase of a patient's breathing cycle based on this time indicator. The feedback signal, on the other hand, can be used by the system interface 170 to communicate with the imaging subsystem 110. For example, if the PTV location shifts out of detection range (or in some other type of manner), the system interface 170 can use the feedback signal to alert the imaging subsystem 110 that such a shift has occurred. The imaging subsystem 110 can accordingly halt operation or adjust image processing (at the processing unit 230) based on the feedback signal.
In other, non-illustrated embodiments, the system interface 170 can be a simple communication link between the imaging subsystem 110 and localization subsystem 140. In several embodiments, the imaging subsystem 110 and the localization subsystem 140 can be configured to communicate signals and transmit data between one another. For example, the processing unit 230 (
In one embodiment, the system interface bins raw image data (or image slices or frames) based on the real-time location of the PTV and outputs motion-compensated image data corresponding to a particular subset of the binned image data. For example, the raw image data can be binned (or filtered) based on a range of locations associated with the PTV (described further with reference to
C. Imaging Subsystems
Described below are examples of various imaging subsystems that can be employed with the imaging and localization system 100. In general, the imaging subsystems described below are CT based imaging systems. However, it is contemplated that other types of imaging subsystems can be employed within embodiments of the imaging and localization system 110, for example, such as those that use other types of radiographic and non-radiographic imaging techniques (e.g., digital tomosynthesis, fluoroscopic, MRI, and/or ultrasonic imaging).
In general, CT imaging methods include employing an X-ray source and detector to scan a patient PTV at a target depth. In many examples, portions of the anatomy adjacent a PTV can be blurred-out of an imaging frame by implementing a variable depth of field between an X-ray source and detector. An imaging frame of a PTV, accordingly, is sharp and detailed, and well contrasted against background anatomy. As described above, modern methods of CT imaging are generally carried out by rotating an X-ray source about a central axis of a gantry bore and using a detector (either stationary or rotating) on an opposite side of the PTV to acquire multiple image “slices” of a PTV. These image slices can accordingly be assembled based on a variety of processing algorithms to produce an image frame.
Embodiments of the imaging subsystem can employ a variety of CT image acquisition techniques, including axial, helical or spiral, or cine CT techniques. In axial CT, a patient table is stationary while an X-ray source rotates (and optionally a detector) about the PTV to acquire image slices. The table can be subsequently moved, and additional image slices can be acquired after the table returns to a stationary position. Such slices can be assembled or aggregated to create a volumetric representation of a PTV. Helical CT is similar to axial CT, but moves the patient smoothly through the gantry bore while concurrently rotating the X-ray source. Helical CT scans are advantageous in that a large patient volume can be acquired in about 20-60 seconds. In addition, Helical CT scans do not have an interscan delay that normally occurs when repositioning the table in axial CT. Ciné CT, on the other hand, produces a time sequence of axial images, and is generally used when the temporal nature of a PTV is important (e.g., to evaluate blood flow).
Additionally, other embodiments of CT systems can further include multislice and/or dual source systems. Multislice CT scanners can employ axial or helical imaging techniques, but are configured to include more than one detector. In general, increasing the number of detectors allows increased x-ray source rotation speeds. For example, modern multi-slice CT systems can include up to 256 detectors, creating up to 256 corresponding slices (simultaneously). Dual source CT systems can similarly employ axial or helical imaging techniques, but have an increased temporal resolution attributed to a reduction in rotation angle required to acquire a complete image. In addition, dual source CT can employ dual energy imaging, which can be used to differentiate between anatomy that would otherwise be unobtainable differentiable with a single source CT system. For example, dual source CT systems may be used to enhance the differentiation between tumors and adjacent tissues.
Embodiments of CT systems that can be incorporated into the imaging subsystem can also include, for example, the SOMATOM™ CT systems manufactured and sold by Siemens AG.
D. Compatibility of Localization Subsystem with Radiation Delivery Devices
In many embodiments, the localization subsystem 140 is used in proximity to a radiation delivering imaging device (e.g., a linear accelerator) of the imaging subsystem 110. Accordingly, aspects of the imaging and localization system 100, and particularly, the localization subsystem 140 may be adversely interfered with by the operation of such a radiation delivery device (not only the emitted radiation, but the circuitry of the delivery component itself). Therefore, the system 100 can be adapted to mitigate adverse influences attributed to the radiation delivery device.
As one example, components of the localization subsystem 140 (e.g., the excitation source, sensor array 354, and signal processing components 360) can be arranged so that radiation does not travel through the localization subsystem 140. For example, referring to
As another example, the localization subsystem 140 can include a matched filter or other device that can detect the presence of interference due to the operation of radiation delivering devices, or any other interfering device that operates in a pulsed mode. If such interference is detected, the localization subsystem 140 can be operative to discard received location signals that occurred in that timeframe. Additionally or alternatively, the localization subsystem 140 can also include radiation hardened circuitry that is generally impervious to ionizing radiation (below a threshold level). Referring again to
E. Experimental Analysis
1. Experimental Setup
An active marker was embedded in wax, placed adjacent to a 2 cm diameter acrylic ball and the two objects placed on a 4D Phantom stage. The 4D Phantom was placed on the table of a CT scanner (Brilliance CT Big Bore Scanner—Philips, Andover, Mass.) and moved in a trajectory recorded from a canine breathing study that was performed using variable forced ventilation. The sensor array of the localization subsystem was placed over the 4D Phantom stage in the gantry bore. A real-time location signal was generated that was synchronized to the CT acquisition while the CT scans were acquired and the localization sub-system monitored the active marker position The CT scanner was operated in a ciné axial mode with 15 acquisitions per table position. Each image was created with a 0.44 second rotation time followed by a 0.5 second dead time. Each table position contained 16 contiguous 1.5 mm thick for a total of 2.4 cm width. There was a 2-4 s pause between adjacent table position acquisitions.
2. Localization Subsystem Performance Measured by 4D Phantom
The accuracy of the localization sub-system in a CT scanner environment was determined by comparing the real-time localization data output to 4D Phantom position.
3. Image Data Processing
Active marker positions were successfully synchronized with the CT images. The longitudinal (in/out of table) position and the associated x-ray on signals from the CT table are shown in
The CT image frames were binned with respect to the measured active marker position. A sample transverse image and its corresponding active marker trace are shown in
F. Conclusion
The above description of illustrated embodiments, including what is described in the Abstract, is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Although specific embodiments of and examples are described herein for illustrative purposes, various equivalent modifications can be made without departing from the spirit and scope of the invention, as will be recognized by those skilled in the relevant art.
The various embodiments described above can be combined to provide further embodiments. For example, aspects of the system interface 170 can be omitted or incorporated into one or both of the imaging and location subsystem (e.g., the communication ports 472 and 474, the processor 476, and the memory 478). In addition, in other embodiments, the system interface 470 can be used more generally to provide a communication link between the imaging and localization subsystems 110 and 140. Further, all the U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications, and non-patent publications referred to in this specification and/or listed in the Application Data Sheet are incorporated herein by reference, in their entirety. Aspects of this disclosure and referenced disclosures can be modified, if necessary, to employ systems, devices, and concepts of the various patents, applications, and publications to provide yet further embodiments.
These and other changes can be made to various embodiments in light of the above-detailed description. In general, in the following claims, the terms used should not be construed as limiting the specific embodiments disclosed in the specification and the claims, but should be construed to include all imaging and localization subsystems (and aspect thereof) that operate in accordance with the claims to provide systems and methods for imaging a selected target volume within a patient based on the real-time location of one or more active markers. Accordingly, the invention is not limited, except as by the appended claims.
This application is a U.S. National Phase of International Patent Application No. PCT/US2009/046494, filed Jun. 5, 2009, and titled MOTION COMPENSATION FOR MEDICAL IMAGING AND ASSOCIATED SYSTEMS AND METHODS, which claims the benefit of U.S. Provisional Patent Application No. 61/059,119, filed Jun. 5, 2008, and titled MOTION COMPENSATION FOR MEDICAL IMAGING AND ASSOCIATED SYSTEMS AND METHODS; the disclosure of each of these applications is incorporated herein by reference in its entirety.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/US2009/046494 | 6/5/2009 | WO | 00 | 6/28/2011 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2009/149409 | 12/10/2009 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 3967161 | Lichtblau | Jun 1976 | A |
| 4017858 | Kuipers | Apr 1977 | A |
| 4023167 | Wahlstrom | May 1977 | A |
| 4114601 | Abels | Sep 1978 | A |
| 4123749 | Hartmann et al. | Oct 1978 | A |
| 4127110 | Bullara | Nov 1978 | A |
| 4160971 | Jones et al. | Jul 1979 | A |
| 4222374 | Sampson et al. | Sep 1980 | A |
| 4260990 | Lichtblau | Apr 1981 | A |
| 4343196 | Wirth et al. | Aug 1982 | A |
| 4393872 | Reznik et al. | Jul 1983 | A |
| 4466075 | Groch | Aug 1984 | A |
| 4618822 | Hansen | Oct 1986 | A |
| 4633250 | Anderson, III et al. | Dec 1986 | A |
| 4642786 | Hansen | Feb 1987 | A |
| 4643196 | Tanaka et al. | Feb 1987 | A |
| 4696287 | Hortmann et al. | Sep 1987 | A |
| 4737794 | Jones | Apr 1988 | A |
| 4795995 | Eccleston et al. | Jan 1989 | A |
| 4799495 | Hawkins et al. | Jan 1989 | A |
| 4849692 | Blood | Jul 1989 | A |
| 4909789 | Taguchi et al. | Mar 1990 | A |
| 4936823 | Colvin et al. | Jun 1990 | A |
| 4945305 | Blood | Jul 1990 | A |
| 4945914 | Allen | Aug 1990 | A |
| 4994079 | Genese et al. | Feb 1991 | A |
| 5031634 | Simon | Jul 1991 | A |
| 5050608 | Watanabe | Sep 1991 | A |
| 5062847 | Barnes | Nov 1991 | A |
| 5095224 | Renger et al. | Mar 1992 | A |
| 5099845 | Besz et al. | Mar 1992 | A |
| 5107862 | Fabian et al. | Apr 1992 | A |
| 5117829 | Miller et al. | Jun 1992 | A |
| 5142292 | Chang | Aug 1992 | A |
| 5170055 | Carroll et al. | Dec 1992 | A |
| 5188368 | Ryan et al. | Feb 1993 | A |
| 5198877 | Schulz | Mar 1993 | A |
| 5221269 | Miller | Jun 1993 | A |
| 5222499 | Allen et al. | Jun 1993 | A |
| 5240011 | Assa | Aug 1993 | A |
| 5325873 | Hirschi et al. | Jul 1994 | A |
| 5353804 | Kornberg et al. | Oct 1994 | A |
| 5377678 | Dumoulin | Jan 1995 | A |
| 5397329 | Allen | Mar 1995 | A |
| 5409004 | Sloan | Apr 1995 | A |
| 5411026 | Carol | May 1995 | A |
| 5417210 | Funda | May 1995 | A |
| 5423334 | Jordan | Jun 1995 | A |
| 5425367 | Shapiro et al. | Jun 1995 | A |
| 5425382 | Golden et al. | Jun 1995 | A |
| 5431161 | Ryals et al. | Jul 1995 | A |
| 5446548 | Gerig | Aug 1995 | A |
| 5453686 | Anderson | Sep 1995 | A |
| 5509900 | Kirkman | Apr 1996 | A |
| 5515853 | Smith | May 1996 | A |
| 5526812 | Dumoulin et al. | Jun 1996 | A |
| 5528651 | Leksell et al. | Jun 1996 | A |
| 5546951 | Ben-Haim | Aug 1996 | A |
| 5558091 | Acker | Sep 1996 | A |
| 5568809 | Ben-Haim | Oct 1996 | A |
| 5572999 | Funda et al. | Nov 1996 | A |
| 5617857 | Chader | Apr 1997 | A |
| 5622170 | Schulz | Apr 1997 | A |
| 5622187 | Carol | Apr 1997 | A |
| 5629967 | Leksell | May 1997 | A |
| 5630431 | Taylor | May 1997 | A |
| 5638819 | Manwaring et al. | Jun 1997 | A |
| 5680106 | Schrott et al. | Oct 1997 | A |
| 5681326 | Lax | Oct 1997 | A |
| 5697384 | Miyawaki et al. | Dec 1997 | A |
| 5707362 | Yoon | Jan 1998 | A |
| 5707390 | Bonutti | Jan 1998 | A |
| 5727552 | Ryan | Mar 1998 | A |
| 5735795 | Young et al. | Apr 1998 | A |
| 5745545 | Hughes | Apr 1998 | A |
| RE35816 | Schulz | Jun 1998 | E |
| 5764052 | Renger | Jun 1998 | A |
| 5769861 | Vilsmeier et al. | Jun 1998 | A |
| 5779638 | Vesely | Jul 1998 | A |
| 5797849 | Vesely et al. | Aug 1998 | A |
| 5805661 | Leksell | Sep 1998 | A |
| 5810851 | Yoon | Sep 1998 | A |
| 5815076 | Herring | Sep 1998 | A |
| 5817022 | Vesely | Oct 1998 | A |
| 5820553 | Hughes | Oct 1998 | A |
| 5823192 | Kalend et al. | Oct 1998 | A |
| 5828770 | Leis et al. | Oct 1998 | A |
| 5830144 | Vesely | Nov 1998 | A |
| 5840148 | Campbell et al. | Nov 1998 | A |
| 5868673 | Vesely | Feb 1999 | A |
| 5868675 | Henrion et al. | Feb 1999 | A |
| 5879297 | Haynor et al. | Mar 1999 | A |
| 5879357 | Heaton | Mar 1999 | A |
| 5899857 | Wilk | May 1999 | A |
| 5902238 | Golden | May 1999 | A |
| 5902310 | Foerster | May 1999 | A |
| 5910144 | Hayashi | Jun 1999 | A |
| 5913820 | Bladen | Jun 1999 | A |
| 5923417 | Leis | Jul 1999 | A |
| 5928137 | Green | Jul 1999 | A |
| 5951481 | Evans | Sep 1999 | A |
| 5987349 | Schulz | Nov 1999 | A |
| 5989265 | Bouquet De La Joliniere et al. | Nov 1999 | A |
| 6015390 | Krag | Jan 2000 | A |
| 6019725 | Vesely et al. | Feb 2000 | A |
| 6026818 | Blair et al. | Feb 2000 | A |
| 6049587 | Leksell et al. | Apr 2000 | A |
| 6052477 | Wang et al. | Apr 2000 | A |
| 6059734 | Yoon | May 2000 | A |
| 6061644 | Leis | May 2000 | A |
| 6064904 | Yanof et al. | May 2000 | A |
| 6067465 | Foo et al. | May 2000 | A |
| 6076008 | Bucholz | Jun 2000 | A |
| 6081238 | Alicot | Jun 2000 | A |
| 6082366 | Andra et al. | Jul 2000 | A |
| 6094007 | Faul | Jul 2000 | A |
| 6097994 | Navab | Aug 2000 | A |
| 6118848 | Reiffel | Sep 2000 | A |
| 6144875 | Schweikard | Nov 2000 | A |
| 6161009 | Skurdal et al. | Dec 2000 | A |
| 6173715 | Sinanan et al. | Jan 2001 | B1 |
| 6198963 | Haim et al. | Mar 2001 | B1 |
| 6239724 | Doron et al. | May 2001 | B1 |
| 6246900 | Cosman et al. | Jun 2001 | B1 |
| 6307473 | Zampini et al. | Oct 2001 | B1 |
| 6325758 | Carol et al. | Dec 2001 | B1 |
| 6363940 | Krag | Apr 2002 | B1 |
| 6371379 | Dames et al. | Apr 2002 | B1 |
| 6381485 | Hunter et al. | Apr 2002 | B1 |
| 6401722 | Krag | Jun 2002 | B1 |
| 6405072 | Cosman | Jun 2002 | B1 |
| 6416520 | Kynast et al. | Jul 2002 | B1 |
| 6474341 | Hunter et al. | Nov 2002 | B1 |
| 6611700 | Vilsmeier et al. | Aug 2003 | B1 |
| 6675810 | Krag | Jan 2004 | B2 |
| 6698433 | Krag | Mar 2004 | B2 |
| 6812842 | Dimmer | Nov 2004 | B2 |
| 6822570 | Dimmer et al. | Nov 2004 | B2 |
| 6838990 | Dimmer | Jan 2005 | B2 |
| 6918919 | Krag | Jul 2005 | B2 |
| 6963770 | Scarantino et al. | Nov 2005 | B2 |
| 7135978 | Gisselberg et al. | Nov 2006 | B2 |
| 7657301 | Mate et al. | Feb 2010 | B2 |
| 7657302 | Mate et al. | Feb 2010 | B2 |
| 7657303 | Mate et al. | Feb 2010 | B2 |
| 20020065461 | Cosman | May 2002 | A1 |
| 20020193685 | Mate et al. | Dec 2002 | A1 |
| 20030088178 | Owens et al. | May 2003 | A1 |
| 20030192557 | Krag et al. | Oct 2003 | A1 |
| 20030206614 | Kendrick et al. | Nov 2003 | A1 |
| 20040092815 | Schweikard et al. | May 2004 | A1 |
| 20040123871 | Wright et al. | Jul 2004 | A1 |
| 20040125916 | Herron et al. | Jul 2004 | A1 |
| 20040133101 | Mate | Jul 2004 | A1 |
| 20040138555 | Krag | Jul 2004 | A1 |
| 20040158146 | Mate | Aug 2004 | A1 |
| 20040176931 | Wright | Sep 2004 | A1 |
| 20040236207 | Widener et al. | Nov 2004 | A1 |
| 20050059884 | Krag | Mar 2005 | A1 |
| 20050140372 | Wright et al. | Jun 2005 | A1 |
| 20050154280 | Wright et al. | Jul 2005 | A1 |
| 20050154293 | Gisselberg | Jul 2005 | A1 |
| 20050195084 | Dimmer et al. | Sep 2005 | A1 |
| 20050201510 | Mostafavi | Sep 2005 | A1 |
| 20050261570 | Mate et al. | Nov 2005 | A1 |
| 20060074301 | Meier et al. | Apr 2006 | A1 |
| 20060074302 | Meier et al. | Apr 2006 | A1 |
| 20060079764 | Wright et al. | Apr 2006 | A1 |
| 20060173294 | Ein-Gal | Aug 2006 | A1 |
| 20070153972 | Fujishige et al. | Jul 2007 | A1 |
| 20080039746 | Hissong et al. | Feb 2008 | A1 |
| 20080226149 | Wischmann et al. | Sep 2008 | A1 |
| 20110046481 | Mate et al. | Feb 2011 | A1 |
| Number | Date | Country |
|---|---|---|
| 19914455 | Oct 2000 | DE |
| 0531081 | Mar 1993 | EP |
| 0 719 420 | Nov 1999 | EP |
| 1 034 738 | Sep 2000 | EP |
| 2635259 | Feb 1990 | FR |
| 2686499 | Jul 1993 | FR |
| 8-166446 | Jun 1996 | JP |
| WO-8808282 | Nov 1988 | WO |
| WO-9525475 | Sep 1995 | WO |
| WO-9533519 | Dec 1995 | WO |
| WO-9608208 | Mar 1996 | WO |
| WO-9608999 | Mar 1996 | WO |
| WO-9712553 | Apr 1997 | WO |
| WO-9736192 | Oct 1997 | WO |
| WO-9748438 | Dec 1997 | WO |
| WO-9830166 | Jul 1998 | WO |
| WO-9838908 | Sep 1998 | WO |
| WO-9840026 | Sep 1998 | WO |
| WO-9917133 | Apr 1999 | WO |
| WO-9927839 | Jun 1999 | WO |
| WO-9930182 | Jun 1999 | WO |
| WO-9933406 | Jul 1999 | WO |
| WO-9935966 | Jul 1999 | WO |
| WO-9940869 | Aug 1999 | WO |
| WO-9953966 | Oct 1999 | WO |
| WO-9958044 | Nov 1999 | WO |
| WO-9958055 | Nov 1999 | WO |
| WO-9958065 | Nov 1999 | WO |
| WO-0024332 | May 2000 | WO |
| WO-0038579 | Jul 2000 | WO |
| WO-0051514 | Sep 2000 | WO |
| WO-0053115 | Sep 2000 | WO |
| WO-0065989 | Nov 2000 | WO |
| WO-0134049 | May 2001 | WO |
| WO-0154765 | Aug 2001 | WO |
| WO-0219908 | Mar 2002 | WO |
| WO-0239917 | May 2002 | WO |
| WO-0239918 | May 2002 | WO |
| WO-02100485 | Dec 2002 | WO |
| WO-2006113323 | Oct 2006 | WO |
| Entry |
|---|
| Beyer, Thomas, et al. “Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology.” European journal of nuclear medicine and molecular imaging 30.4 (2003): 588-596. |
| Low, Daniel A., et al. “A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing.” Medical physics 30.6 (2003): 1254-1263. |
| Wolthaus, J. W. H., et al. “Fusion of respiration-correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans.” Physics in medicine and biology 50.7 (2005): 1569. |
| U.S. Appl. No. 10/416,827, Krag. |
| Final Office Action, U.S. Appl. No. 09/877,498, Applicant: Calypso Medical Technologies, Inc., Date of Mailing: Feb. 14, 2006, 7 pages. |
| Decision on Appeal, U.S. Appl. No. 09/877,498, Applicant: Calypso Medical Technologies, Inc., Date of Mailing: May 27, 2009, 16 pages. |
| Final Office Action; U.S. Appl. No. 09/877,498; Applicant: Calypso Medical Technologies, Inc.; Date of Mailing: Feb. 14, 2006; 7 pages. |
| Hsiao, K., “Fast Multi-Axis Tracking of Magnetically-Resonant Passive Tags: Methods and Applications,” Feb. 2001, Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, pp. 1-107. |
| International Preliminary Examination Report; PCT/US02/17876, filed Jun. 5, 2002, in the name of Calypso Medical Technologies, Inc. |
| International Search Report dated Jan. 24, 2003, PCT Application No. PCT/US/29390. |
| European Search Report dated Jun. 28, 2011, EP Application No. 10185512. |
| International Search Report and Written Opinion dated Jul. 28, 2009, PCT Application No. US09/046494, 12 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20110249880 A1 | Oct 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61059119 | Jun 2008 | US |